Cytokinetics Inc
(NAS:CYTK)
$
51.94
-0.84 (-1.59%)
Market Cap: 6.09 Bil
Enterprise Value: 6.32 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 41/100 - Q1 2024 Cytokinetics Inc Earnings Call TranscriptMay 08, 2024$65.27 (-0.02%)Earnings
- Q4 2023 Cytokinetics Inc Earnings Call TranscriptFeb 27, 2024$80.99 (+2.52%)Earnings
- Cytokinetics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Cytokinetics Inc to Discuss the Topline Results from SEQUOIA-HCM TranscriptDec 27, 2023
- Cytokinetics Inc at UBS BioPharma Conference TranscriptNov 08, 2023
- Q3 2023 Cytokinetics Inc Earnings Call TranscriptNov 02, 2023$34.64 (-1.31%)Earnings
- Cytokinetics Inc To Host Virtual Investor & Analyst Day TranscriptOct 19, 2023
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Cytokinetics Inc Earnings Call TranscriptAug 03, 2023$31.7 (+1.99%)Earnings
- Cytokinetics Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Cytokinetics Inc at Jefferies Healthcare Conference TranscriptJun 08, 2023
- Cytokinetics Inc at JMP Securities Life Sciences Conference TranscriptMay 15, 2023
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 10, 2023
- Q1 2023 Cytokinetics Inc Earnings Call TranscriptMay 04, 2023$39.29 (-0.13%)Earnings
- Cytokinetics Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Cytokinetics Inc To Discuss COURAGE-ALS Update Call TranscriptMar 31, 2023
- Cytokinetics Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Cytokinetics Inc ACC.23 Conference Call TranscriptMar 06, 2023
- Q4 2022 Cytokinetics Inc Earnings Call TranscriptMar 01, 2023$43.11 (-0.58%)Earnings
- Cytokinetics Inc To Discuss Omecamtiv Mecarbil Regulatory Update Call TranscriptMar 01, 2023
- Cytokinetics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Cytokinetics Inc FDA Advisory Committee for Omecamtiv Mecarbill Update Call TranscriptDec 14, 2022
- Q3 2022 Cytokinetics Inc Earnings Call TranscriptNov 03, 2022$39.75 (-5.06%)Earnings
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Cytokinetics Inc Earnings Call TranscriptAug 04, 2022$46.72 (+9.06%)Earnings
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 10, 2022
- Q1 2022 Cytokinetics Inc Earnings Call TranscriptMay 04, 2022$41.03 (+2.58%)Earnings
- Cytokinetics Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Q4 2021 Cytokinetics Inc Earnings Call TranscriptFeb 24, 2022$33.95 (+8.29%)Earnings
- Cytokinetics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Cytokinetics Inc and Royalty Pharma Funding Agreements Call TranscriptJan 07, 2022
- Cytokinetics Inc and Ji Xing Pharmaceuticals Ltd Call to Discuss Announced Expansion of Collaboration TranscriptDec 20, 2021
- Q3 2021 Cytokinetics Inc Earnings Call TranscriptNov 03, 2021$36.67 (+5.74%)Earnings
- Cytokinetics Inc Analyst and Investor Day TranscriptOct 07, 2021
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Cytokinetics Inc Call to Discuss the Full Results from REDWOOD-HCM TranscriptSep 13, 2021
- Q2 2021 Cytokinetics Inc Earnings Call TranscriptAug 05, 2021$30.24 (+2.47%)Earnings
- Cytokinetics Inc to Discuss Positive Topline Results of Redwood-HCM Call TranscriptJul 19, 2021
- Cytokinetics Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 21, 2021
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 12, 2021
- Q1 2021 Cytokinetics Inc Earnings Call TranscriptMay 06, 2021$23.37 (-0.89%)Earnings
- Cytokinetics Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 11, 2021
- Q4 2020 Cytokinetics Inc Earnings Call TranscriptFeb 25, 2021$19.85 (-4.34%)Earnings
- Cytokinetics Inc Investor Event TranscriptNov 23, 2020
- Cytokinetics Inc GALACTIC-HF Investor/Media Event TranscriptNov 13, 2020
- Q3 2020 Cytokinetics Inc Earnings Call TranscriptNov 04, 2020$18 (+7.66%)Earnings
- Cytokinetics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Cytokinetics Inc Earnings Call TranscriptAug 06, 2020$21.64 (-2.21%)Earnings
- Cytokinetics Inc Virtual Analyst & Investor Day TranscriptJul 15, 2020
- Cytokinetics Inc Licensing Collaboration And Royalty Monetization Deals With RTW Investments Focused To CK-274 Corporate Call TranscriptJul 14, 2020
- Cytokinetics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 13, 2020
- Q1 2020 Cytokinetics Inc Earnings Call TranscriptMay 06, 2020$16.63 (+1.28%)Earnings
- Q4 2019 Cytokinetics Inc Earnings Call TranscriptMar 03, 2020$14.57 (+2.32%)Earnings
- Q3 2019 Cytokinetics Inc Earnings Call TranscriptOct 31, 2019$11.65 (-1.60%)Earnings
- Cytokinetics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Cytokinetics Inc Earnings Call TranscriptAug 08, 2019$13.63 (+2.02%)Earnings
- Cytokinetics Inc at JMP Securities Life Science Conference TranscriptJun 19, 2019
- Cytokinetics Inc Annual Shareholders Meeting TranscriptMay 15, 2019
- Q1 2019 Cytokinetics Inc Earnings Call TranscriptMay 09, 2019$9.01 (+0.78%)Earnings
- Cytokinetics Inc Discusses Results from FORTITUDE-ALS TranscriptMay 06, 2019
- Cytokinetics Inc at Needham Healthcare Conference TranscriptApr 10, 2019
- Cytokinetics Inc at H C Wainwright Global Life Sciences Conference TranscriptApr 08, 2019
- Q4 2018 Cytokinetics Inc Earnings Call TranscriptFeb 21, 2019$7.21 (-1.77%)Earnings
Cytokinetics Inc at UBS BioPharma Conference Transcript
Nov 08, 2023 / 06:00PM GMT
Release Date Price:
$34.76
(-3.04%)
Ashwani Verma
UBS Investment Bank, Research Division - Director of Americas Equity Research & US Specialty Pharma Analyst
All right. Good day, everybody. My name is Ash Verma. Welcome to UBS Biopharma Conference in Miami. Our next company on the stage is Cytokinetics. And with me, we have Andrew Callos, who will be Chief Commercial Officer; and Fady Malik, who is the EVP of R&D. How are you guys doing today?
Fady Ibraham Malik
Cytokinetics, Incorporated - EVP of Research & Development
Doing well.
Questions & Answers
Ashwani Verma
UBS Investment Bank, Research Division - Director of Americas Equity Research & US Specialty Pharma Analyst
Great. Thanks for joining us. So since Andrew, you're sitting next to me, so maybe I can start off with some commercial questions first. And I guess maybe just to preface that, like it will be helpful to get a little bit of a background about the story. So if you can just give us a high-level outline for people who might not be familiar about Cytokinetics,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)